- Q1 2024 Neurocrine Biosciences Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 07, 2024€133.55 (+1.06%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Neurocrine Biosciences Inc To Host Analyst Day TranscriptDec 05, 2023
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Neurocrine Biosciences Inc Earnings Call TranscriptOct 31, 2023Earnings
- Neurocrine Biosciences Inc To Report Crinecerfont PhIII Congenital Adrenal Hyperplasia Results TranscriptOct 05, 2023
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Neurocrine Biosciences Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Neurocrine Biosciences Inc Earnings Call TranscriptAug 01, 2023€91.96 (-0.73%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Neurocrine Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Neurocrine Biosciences Inc Earnings Call TranscriptMay 03, 2023€92.2 (-3.35%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Neurocrine Biosciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 06, 2023€97.48 (-0.04%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call TranscriptJan 09, 2023
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2022€115.86 (+2.13%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Neurocrine Biosciences Inc Earnings Call TranscriptAug 04, 2022€91.77 (+1.16%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Neurocrine Biosciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Neurocrine Biosciences Inc Earnings Call TranscriptMay 04, 2022€83.83 (-2.92%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Needham Neuroscience Forum (Virtual) TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 11, 2022€68.42 (-2.92%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2021€90.78 (+4.20%)Earnings
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2021€80.44 (+2.63%)Earnings
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Neurocrine Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Neurocrine Biosciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Neurocrine Biosciences Inc Earnings Call TranscriptMay 05, 2021€75.8 (+0.21%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Day TranscriptApr 01, 2021
- Neurocrine Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Neurocrine Biosciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2021€93.08 (-0.68%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat TranscriptNov 23, 2020
- Neurocrine Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Neurocrine Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 Neurocrine Biosciences Inc Earnings Call TranscriptNov 09, 2020€83.2 (-0.07%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Neurocrine Biosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptAug 06, 2020
- Q2 2020 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2020€104.15 (+2.97%)Earnings
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 22, 2020
- Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders TranscriptJun 16, 2020
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Neurocrine Biosciences Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Neurocrine Biosciences Inc Earnings Call TranscriptMay 06, 2020€93.68 (+3.15%)Earnings
- Neurocrine Biosciences Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2020€91.14 (+0.91%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Neurocrine Biosciences Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 20, 2019
- Neurocrine Biosciences Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Neurocrine Biosciences Inc Earnings Call TranscriptNov 04, 2019€94.86 (+6.92%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 Neurocrine Biosciences Inc Earnings Call TranscriptJul 29, 2019€77.7 (+2.37%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 06, 2019
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Neurocrine Biosciences Inc Earnings Call TranscriptApr 29, 2019€68.7 (-0.23%)Earnings
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Neurocrine Biosciences Inc at Cowen Health Care Conference TranscriptMar 12, 2019
Neurocrine Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good morning, and welcome to Day 2 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays.
I am pleased to welcome Neurocrine Biosciences, just recently celebrating your 30th Anniversary. Joining us on stage, Kevin Gorman, CEO; and CFO, Matt Abernethy.
Kevin is going to make some opening comments.
I will make -- I'll keep them brief. And I want to thank Barclays, I want to thank you, Carter, for the invitation here. We always love coming to this conference in Miami. I would also say that we are going to be making forward-looking statements. So I would -- you to our more recent SEC filings.
So as Carter said, Neurocrine just recently celebrated its 30th Anniversary. We are a (inaudible) world neuroscience company. What does neuroscience mean to us? That means neurology, neuropsychiatry and neuroendocrinology and hopefully, someday,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)